Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
04/01/2004 | CA2492319A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
03/31/2004 | EP1401830A2 Quinazolinediones as antibacterial agents |
03/31/2004 | EP1401820A1 5-ht receptor ligands and uses thereof |
03/31/2004 | EP1401819A1 5-ht receptor ligands and uses thereof |
03/31/2004 | EP1401818A2 Targeted multivalent macromolecules |
03/31/2004 | EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone |
03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
03/31/2004 | EP0981958B1 Insecticidal/acaricidal agents |
03/31/2004 | EP0781766B1 Heterocyclic derivative and medicine |
03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
03/31/2004 | CN1486170A Couplers for use in oxidative hair dyeing |
03/31/2004 | CN1143853C Preparing method for anti-viral compounds |
03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
03/30/2004 | US6713650 ABCA-1 elevating compounds |
03/30/2004 | US6713486 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
03/30/2004 | US6713485 Antiproliferative agents; side effect reduction |
03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
03/25/2004 | WO2004024703A1 Process for the preparation of 4- (3’-chloro-4’-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
03/25/2004 | WO2004024701A1 Heterocyclic derivatives |
03/25/2004 | WO2004024700A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
03/25/2004 | WO2004024680A1 Alkyl-s-alkyl hydrazone compounds with insecticide, fungicide, herbicide activities and their preparation |
03/25/2004 | WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease |
03/25/2004 | WO2004024162A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
03/25/2004 | WO2004024161A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properites |
03/25/2004 | WO2004024159A1 INHIBITORS OF TFGβ |
03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
03/25/2004 | WO2004006927A3 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors |
03/25/2004 | WO2004000820A3 Certain aromatic monocycles as kinase modulators |
03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
03/25/2004 | US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use |
03/25/2004 | US20040058942 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcuim channel blockers |
03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
03/25/2004 | CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
03/25/2004 | CA2498460A1 Inhibitors of tfg.beta. |
03/25/2004 | CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease |
03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
03/24/2004 | EP1400516A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage |
03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
03/24/2004 | EP1400244A1 New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
03/24/2004 | EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
03/24/2004 | EP1399427A1 Process for the preparation of azoxystrobin and analogues thereof |
03/24/2004 | EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production |
03/24/2004 | EP1399421A1 Substituted imidates as pesticidal agents |
03/24/2004 | EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties |
03/24/2004 | EP1131318B1 Process for making 5-substituted pyrazoles using dithietanes |
03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
03/24/2004 | EP0904079B1 Antidiabetic agents |
03/24/2004 | CN1484634A Alkylthio-and aryl (heteroyl) thio substituted p-phenylenediamines their manufacture and their use in rubber |
03/24/2004 | CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof |
03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
03/24/2004 | CN1142919C Quinazoline derivatives as antitumor agents |
03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
03/23/2004 | US6710178 Preparation of 4-(4-flourophenyl)-6-alkyl-2-N-alkansulfonyl-N-alkylamino)pyrimidine-5-carboxylic acid ester |
03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
03/23/2004 | US6710052 Anticancer agents |
03/23/2004 | US6710045 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (IV) |
03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
03/18/2004 | WO2004022554A1 Quinazolinone derivatives |
03/18/2004 | WO2004022547A1 Phenethanolamine derivatives and their use in the treatment of respiratory diseases |
03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
03/18/2004 | WO2004022054A1 Pyrazolopyridines and methods of making and using the same |
03/18/2004 | WO2004021989A2 Imidazolopyridines and methods of making and using the same |
03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
03/18/2004 | WO2003106432A8 Method for producing 4,6-dichloro-5-fluoropyrimidine |
03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
03/18/2004 | US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders |
03/18/2004 | US20040054181 Chlorination using phospgene; chemical intermediate for drugs, pesticides, fungicides |
03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
03/18/2004 | US20040053952 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
03/18/2004 | US20040053937 Pyrimidine compounds |
03/18/2004 | US20040053927 Certain amino-substituted monocycles as kinase modulators |
03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
03/18/2004 | US20040053815 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides |
03/18/2004 | CA2497970A1 Pyrazolopyridines and methods of making and using the same |
03/18/2004 | CA2497968A1 Imidazolopyridines and methods of making and using the same |
03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
03/17/2004 | EP1398032A1 4-Oxo-quinazolines as LXR nuclear receptor binding compounds |
03/17/2004 | EP1397505A2 Characterising polypeptides |
03/17/2004 | EP1397351A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
03/17/2004 | EP1244634B1 Substituted benzoylcyclohexane diones for use as herbicides |
03/17/2004 | EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds |
03/17/2004 | CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
03/17/2004 | CN1142150C Pyrimidinoxy salicylic acid derivative |